Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02597790 · ClinicalTrials.gov registry record
A Prospective, Longitudinal Study of Endothelial Function in HIV/HCV Coinfected Subjects
A clinical trial, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- 87
- Enrollment target
NCT02597790: Completed study, sponsored by University of California, Los Angeles.
NCT02597790 is a clinical trial that has completed, run by University of California, Los Angeles. The registered enrollment target is 87 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02597790 has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- 87 participants
- Enrollment target
Study Summary
The CTSI-PLACE Study is a study for men and women with HIV/hepatitis C co-infection or HIV only. The study looks at the impact of having hepatitis C virus in addition to HIV on risk for cardiovascular disease. Participants will undergo non-invasive assessment of cardiovascular disease risk through measurements of endothelial function and blood biomarkers at baseline and 1 year (or 4 weeks and 24 weeks after end of HCV treatment for those that undergo HCV treatment during study follow-up).
Primary Outcome
Ratio of the average pulse wave amplitude (PWA) over a 1 minute interval starting 1 minute following cuff release to the pre-occlusion PWA (average over 3.5 minutes pre-cuff inflation)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2013-10 |
| Est. Completion | 2020-01 |
What the finished NCT02597790 record still lists
NCT02597790 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 87 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02597790 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02597790 about?
NCT02597790 is a clinical study titled "A Prospective, Longitudinal Study of Endothelial Function in HIV/HCV Coinfected Subjects". The CTSI-PLACE Study is a study for men and women with HIV/hepatitis C co-infection or HIV only. The study looks at the impact of having hepatitis C virus in addition to HIV on risk for cardiovascular disease. Participants will undergo non-invasive assessment of cardiovascular disease risk through m...
What is the current status of trial NCT02597790?
This trial is currently completed. The enrollment target is 87 participants. The study started on 2013-10. Estimated completion is 2020-01.
Who is sponsoring clinical trial NCT02597790?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03292601 · 87 participants · NA
Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)
- NCT04291105 · 87 participants · Phase 2
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- NCT04565795 · 87 participants · NA
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
- NCT05607004 · 87 participants · Phase 2
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia